Literature DB >> 11273439

Ethical implications in the allocation of scarce medical resources in Poland.

T Tolloczko1.   

Abstract

The health care system in Poland is undergoing major change and it is possible that these changes could affect clinical research. Therefore, the situation of funding of health care is important for the future of medical research in this country. Some questions relevant in this field will be addressed. Since funds for health care and scientific research remain inadequate, their allocation raises moral, economic, legal and organisational dilemmas. The clinical aspects of resource allocation also include physicians' responsibilities towards their patients. Scientific research, clinical medicine, and clinical research have a common denominator: they rely on trust. The physician should be a fiduciary of the patient as well as being a researcher for the benefit of the patient and for society. Some physicians and researchers, despite unethical conduct, escape disclosure and punishment, but decision-makers who wrongly allocate funds for health care and research are never held accountable for their actions.

Entities:  

Keywords:  Biomedical and Behavioral Research; Health Care and Public Health

Mesh:

Year:  2000        PMID: 11273439     DOI: 10.1007/s11948-000-0024-0

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN: 1353-3452            Impact factor:   3.525


  3 in total

1.  Ethical foundations of the Clinton administration's proposed health care system.

Authors:  D W Brock; N Daniels
Journal:  JAMA       Date:  1994-04-20       Impact factor: 56.272

2.  Evaluation of the research norms of scientists and administrators responsible for academic research integrity.

Authors:  S G Korenman; R Berk; N S Wenger; V Lew
Journal:  JAMA       Date:  1998-01-07       Impact factor: 56.272

3.  Cost-effectiveness analysis in a setting of budget constraints--is it equitable?

Authors:  P A Ubel; M L DeKay; J Baron; D A Asch
Journal:  N Engl J Med       Date:  1996-05-02       Impact factor: 91.245

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.